Literature DB >> 12665622

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.

Julia Kurth1, Martin-Leo Hansmann, Klaus Rajewsky, Ralf Küppers.   

Abstract

To assess the impact of the germinal center (GC) reaction on viral spread in Epstein-Barr virus (EBV) infection, we isolated EBV(+) GC B cells from the tonsils of two infectious mononucleosis patients, sequenced their rearranged V genes, and determined expression of the EBV latency genes EBV nuclear antigen 2 and latent membrane protein 1. Most EBV(+) GC B cells belonged to clones of cells harboring somatically mutated V gene rearrangements. Ongoing somatic hypermutation, the hallmark of the GC reaction, was seen only in uninfected GC B cell clones, not in EBV(+) B cell clones. Thus, in infectious mononucleosis, GC and/or memory B cells are directly infected by EBV and expand without somatic hypermutation, whereas the GC passage of EBV-infected naive B cells does not contribute detectably to the generation of infected memory B cells, the main reservoir of EBV during persistence. Most, if not all, EBV-infected cells in GCs exhibited an unusual EBV gene expression pattern in that they were positive for EBV nuclear antigen 2 but negative for latent membrane protein 1. Although the three main types of EBV-associated B cell lymphomas (Burkitt's, Hodgkin's, and posttransplant lymphomas) presumably are derived from GC B cells, EBV(+) GC B cells resembling these EBV(+) GC B cell lymphomas in terms of EBV gene expression and somatic hypermutation pattern could not be identified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665622      PMCID: PMC153624          DOI: 10.1073/pnas.2627966100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Cellular origin of human B-cell lymphomas.

Authors:  R Küppers; U Klein; M L Hansmann; K Rajewsky
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

2.  Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Authors:  R G Caldwell; J B Wilson; S J Anderson; R Longnecker
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

3.  Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease.

Authors:  H Kanzler; R Küppers; S Helmes; H H Wacker; A Chott; M L Hansmann; K Rajewsky
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.

Authors:  I Araujo; H D Foss; M Hummel; I Anagnostopoulos; H S Barbosa; A Bittencourt; H Stein
Journal:  J Pathol       Date:  1999-02       Impact factor: 7.996

5.  Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

Authors:  O Gires; U Zimber-Strobl; R Gonnella; M Ueffing; G Marschall; R Zeidler; D Pich; W Hammerschmidt
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

6.  EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency.

Authors:  J Kurth; T Spieker; J Wustrow; G J Strickler; L M Hansmann; K Rajewsky; R Küppers
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

7.  Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.

Authors:  E Kilger; A Kieser; M Baumann; W Hammerschmidt
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

8.  Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis.

Authors:  G Niedobitek; E Kremmer; H Herbst; L Whitehead; C W Dawson; E Niedobitek; C von Ostau; N Rooney; F A Grässer; L S Young
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

9.  Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Authors:  J Uchida; T Yasui; Y Takaoka-Shichijo; M Muraoka; W Kulwichit; N Raab-Traub; H Kikutani
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

10.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

Authors:  H Kanzler; R Küppers; M L Hansmann; K Rajewsky
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  44 in total

1.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 2.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 3.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.

Authors:  Francesco Boccellato; Eleni Anastasiadou; Paola Rosato; Bettina Kempkes; Luigi Frati; Alberto Faggioni; Pankaj Trivedi
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

5.  Cellular target genes of Epstein-Barr virus nuclear antigen 2.

Authors:  Sabine Maier; Gabriele Staffler; Andrea Hartmann; Julia Höck; Karen Henning; Kristina Grabusic; Reinhard Mailhammer; Reinhard Hoffmann; Matthias Wilmanns; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

Authors:  Vey Hadinoto; Michael Shapiro; Thomas C Greenough; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

Review 7.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

8.  Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection.

Authors:  Barbro Ehlin-Henriksson; Wu Liang; Alberto Cagigi; Frida Mowafi; George Klein; Anna Nilsson
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

Review 9.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

10.  Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population.

Authors:  Margaret Conacher; Robin Callard; Karen McAulay; Helen Chapel; David Webster; Dinakantha Kumararatne; Anita Chandra; Gavin Spickett; Paul A Hopwood; Dorothy H Crawford
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.